<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLOS ONE</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9642874</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pone.0277340</article-id>
    <article-id pub-id-type="publisher-id">PONE-D-22-22514</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Urine</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Anatomy</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Urine</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Body Fluids</subject>
            <subj-group>
              <subject>Urine</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Blood Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Cell Biology</subject>
          <subj-group>
            <subject>Cellular Types</subject>
            <subj-group>
              <subject>Animal Cells</subject>
              <subj-group>
                <subject>Immune Cells</subject>
                <subj-group>
                  <subject>White Blood Cells</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune Cells</subject>
            <subj-group>
              <subject>White Blood Cells</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Urology</subject>
          <subj-group>
            <subject>Genitourinary Infections</subject>
            <subj-group>
              <subject>Urinary Tract Infections</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Computer Applications</subject>
          <subj-group>
            <subject>Web-Based Applications</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Health Care</subject>
          <subj-group>
            <subject>Geriatric Care</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Spectrum Analysis Techniques</subject>
          <subj-group>
            <subject>Spectrophotometry</subject>
            <subj-group>
              <subject>Cytophotometry</subject>
              <subj-group>
                <subject>Flow Cytometry</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Computer Architecture</subject>
          <subj-group>
            <subject>User Interfaces</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Engineering and Technology</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>FlowUTI: An interactive web-application for optimizing the use of flow cytometry as a screening tool in urinary tract infections</article-title>
      <alt-title alt-title-type="running-head">FlowUTI: A shiny web-application to establish optimal cut-off values in urine flow-cytometry</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3456-9532</contrib-id>
        <name>
          <surname>Martín-Gutiérrez</surname>
          <given-names>Guillermo</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Martín-Pérez</surname>
          <given-names>Carlos</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Toledo</surname>
          <given-names>Héctor</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sánchez-Cantalejo</surname>
          <given-names>Emilio</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff004" ref-type="aff">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3635-4930</contrib-id>
        <name>
          <surname>Lepe</surname>
          <given-names>José Antonio</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain</addr-line>
    </aff>
    <aff id="aff004">
      <label>4</label>
      <addr-line>Retired, Spain</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Al-Judaibi</surname>
          <given-names>Awatif Abid</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>University of Jeddah, SAUDI ARABIA</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>gmartin-ibis@us.es</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>8</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>17</volume>
    <issue>11</issue>
    <elocation-id>e0277340</elocation-id>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>25</day>
        <month>10</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 Martín-Gutiérrez et al</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>Martín-Gutiérrez et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pone.0277340.pdf"/>
    <abstract>
      <p>Due to the high prevalence of patients attending with urinary tract infection (UTI) symptoms, the use of flow-cytometry as a rapid screening tool to avoid unnecessary cultures is becoming a widely used system in clinical practice. However, the recommended cut-points applied in flow-cytometry systems differ substantially among authors, making it difficult to obtain reliable conclusions. Here, we present FlowUTI, a shiny web-application created to establish optimal cut-off values in flow-cytometry for different UTI markers, such as bacterial or leukocyte counts, in urine from patients with UTI symptoms. This application provides a user-friendly graphical interface to perform robust statistical analysis without a specific training. Two datasets are analyzed in this manuscript: one composed of 204 urine samples from neonates and infants (≤3 months old) attended in the emergency department with suspected UTI; and the second dataset including 1174 urines samples from an elderly population attended at the primary care level. The source code is available on GitHub (<ext-link xlink:href="https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI" ext-link-type="uri">https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI</ext-link>). The web application can be executed locally from the R console. Alternatively, it can be freely accessed at <ext-link xlink:href="https://covidiario.shinyapps.io/flowuti/" ext-link-type="uri">https://covidiario.shinyapps.io/flowuti/</ext-link>. FlowUTI provides an easy-to-use environment for evaluating the efficiency of the urinary screening process with flow-cytometry, reducing the computational burden associated with this kind of analysis.</p>
    </abstract>
    <funding-group>
      <funding-statement>The author(s) received no specific funding for this work.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="2"/>
      <table-count count="2"/>
      <page-count count="9"/>
    </counts>
    <custom-meta-group>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All data are fully available without restriction from: <ext-link xlink:href="https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI" ext-link-type="uri">https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All data are fully available without restriction from: <ext-link xlink:href="https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI" ext-link-type="uri">https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI</ext-link>.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>Urinary tract infections (UTIs) are among the most common bacterial infections in humans, representing the second most frequent community-acquired infection in women [<xref rid="pone.0277340.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0277340.ref002" ref-type="bibr">2</xref>]. That being so, it is no wonder that urine specimens are one of the most received samples in clinical microbiology laboratories [<xref rid="pone.0277340.ref003" ref-type="bibr">3</xref>]. Urine culture is the gold-standard method for UTI to detect the causative agent and initiate an appropriate antibiotic treatment. However, most of the samples have a negative result (over 60%) [<xref rid="pone.0277340.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0277340.ref006" ref-type="bibr">6</xref>], consuming time and resources in their processing, and thus increasing workload and costs.</p>
    <p>Several screening tests are used in clinical microbiology laboratories to rule out negative urine samples. In this sense, flow cytometry has become one of the most used screening tools, allowing to inform negative results earlier, reducing time, costs and unnecessary empirical antibiotic treatments [<xref rid="pone.0277340.ref007" ref-type="bibr">7</xref>–<xref rid="pone.0277340.ref009" ref-type="bibr">9</xref>]. Nevertheless, although the usefulness of flow-cytometry as a screening tool has been well established for patients with UTI symptoms, bacteria and leukocyte cut-off values applied vary significantly across studies [<xref rid="pone.0277340.ref010" ref-type="bibr">10</xref>]. This issue can be explained by two main facts: i) the basic measures to validate the diagnostic tests are expected to vary strongly depending on disease prevalence [<xref rid="pone.0277340.ref011" ref-type="bibr">11</xref>], and UTI prevalence varies greatly with age, gender and underlying diseases [<xref rid="pone.0277340.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0277340.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0277340.ref013" ref-type="bibr">13</xref>]; ii) Additionally, the interpretation of the quantitative results obtained depends on the threshold applied, which also varies according to the clinical characteristics of the patients [<xref rid="pone.0277340.ref014" ref-type="bibr">14</xref>]. Therefore, due to the heterogeneity of the patients analyzed in the different studies, it is difficult to compare the cut-off values applied or to derive reliable conclusions. Consequently, the best choice for microbiology laboratories is to set their own cut-off values according to patients attended in their health centers, in order to improve the reliability of the screening.</p>
    <p>Well-designed interactive tools empower users to integrate information and discover new associations without requiring programming knowledge or data-analytic skills. Considering the powerful functions in R [<xref rid="pone.0277340.ref015" ref-type="bibr">15</xref>], a practical open language for statistical and graphical exploration of data set, and the versatility of Shiny [<xref rid="pone.0277340.ref016" ref-type="bibr">16</xref>], a free web application that does not require knowledge of any programming language, we developed FlowUTI, the first openly available shiny web-application created to determine optimal cut-off values for different UTI markers from flow cytometry systems. In addition, with the aim of evaluating FlowUTI, two datasets obtained with two different flow cytometry systems are analyzed in this manuscript.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Methods</title>
    <sec id="sec003">
      <title>FlowUTI development</title>
      <p>The source code of the web application is written in the R language [<xref rid="pone.0277340.ref015" ref-type="bibr">15</xref>], developed by using the function “epi.test” of the R-package epiR [<xref rid="pone.0277340.ref017" ref-type="bibr">17</xref>] and the R-package pROC [<xref rid="pone.0277340.ref018" ref-type="bibr">18</xref>]. We used a specific code to compute the most consistent diagnostic parameters used in clinical studies. Data manipulation and data analysis were executed using R-scripts, which rely on CRAN packages including: ggplot2, dplyr, xtable, shinythemes, knitr and rmarkdown. A shiny web application [<xref rid="pone.0277340.ref016" ref-type="bibr">16</xref>] was created with the aim of providing an accessible tool for non-R users. We used the web application server Shiny to create a robust graphical user interface, which allows an interactive manipulation and interaction with the application.</p>
    </sec>
    <sec id="sec004">
      <title>Workflow</title>
      <p><xref rid="pone.0277340.g001" ref-type="fig">Fig 1</xref> shows the workflow graph. First, urines from patients with a suspected UTI are cultured according to national or international guidelines for the diagnosis of UTIs [<xref rid="pone.0277340.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0277340.ref020" ref-type="bibr">20</xref>]. Additionally, urines are analyzed by flow-cytometry according to the manufacturer’s instructions. Once urines have been analyzed, the results are transferred to a spreadsheet software. The minimum data set required to run the application comprises the culture result, that must be a dichotomous variable (that hold precisely two distinct values, such as “Positive” and “Negative” results), and the variable of interest obtained by flow cytometry, such us bacteria count. The data set can be supplemented with additional variables (leukocyte, epithelial cells, yeasts, etc.). Finally, each spreadsheet is saved as its own Comma Separated Value (.csv) file. These .csv files are easily obtained from Excel or R software.</p>
      <fig position="float" id="pone.0277340.g001">
        <object-id pub-id-type="doi">10.1371/journal.pone.0277340.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>FlowUTI workflow.</title>
          <p>Flow cytometry figure was adapted from <ext-link xlink:href="http://www.cytognos.com" ext-link-type="uri">www.cytognos.com</ext-link>, and csv figure from <ext-link xlink:href="http://www.shareicon.net" ext-link-type="uri">www.shareicon.net</ext-link>.</p>
        </caption>
        <graphic xlink:href="pone.0277340.g001" position="float"/>
      </fig>
    </sec>
    <sec id="sec005">
      <title>Using the application</title>
      <p>FlowUTI is able to work with data from any flow-cytometry analyzer, regardless of the brand or model. First, in the <italic toggle="yes">Upload data</italic> section, the users will upload to FlowUTI the .csv file. Additionally, in the <italic toggle="yes">Upload data</italic> section, two demo datasets can be uploaded as examples of the data format needed for running the model, where the users can learn and be trained to work with the application before introducing their own data. The information about the patients’ characteristics included in these datasets is described further on. Once the document is uploaded, the user can preview the dataset.</p>
      <p>In the section <italic toggle="yes">Diagnostic accuracy</italic>, the user can explore the diagnostic parameters obtained according to the selected cut-off value (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2</xref>). Firstly, the user selects the independent variable of concern (bacteria or leukocyte) and the dependent variable (culture result, the gold standard) (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2A</xref>). After that, the cut-off values can be selected by clicking on the slider bar. Immediately, the application will run the computations and will display a table with all diagnostic parameters obtained according to the selected cut-off (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2B</xref>). The lower and higher values for bacteria or leukocytes can be chosen to optimize the selection of the cut-off value (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2C</xref>). In addition, the application generates a density distribution graph (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2D</xref>), showing the positive and negative cultures distribution according to bacteria or leukocyte counts. In this interactive chart the users can zoom in and out, which will help visually to consider the best cut-off value. In this section, the users can also generate a summary document in .pdf format by clicking in the “Report” button (<xref rid="pone.0277340.g002" ref-type="fig">Fig 2E</xref>), gathering all the results according to the selected cut-off value, depending on the user’s choice.</p>
      <fig position="float" id="pone.0277340.g002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0277340.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Screenshot of the FlowUTI diagnostic accuracy browser, showing the results obtained for bacterial counts corresponding to the neonate demo dataset.</title>
        </caption>
        <graphic xlink:href="pone.0277340.g002" position="float"/>
      </fig>
      <p>Finally, in the section <italic toggle="yes">Tables of sensitivity and specificity</italic>, the discrimination power of bacteria and leukocyte counts are assessed by Receiver Operating Characteristic (ROC) curve analysis. As was performed in the last section, the user selects the independent and dependent variables of interest, and then the sensitivity, specificity, and the area under the curve (AUC), which is the measure of the ability of a classifier to distinguish between classes, used as a summary of the ROC curve (the higher the AUC, the better the performance of the model at distinguishing between the positive and negative classes), are immediately calculated using bootstrapping (n = 1000). Additionally, placed at the right side, the sensitivity-specificity and ROC curves are plotted.</p>
    </sec>
    <sec id="sec006">
      <title>Web application</title>
      <p>We host the web application on the Shiny server at the web address <ext-link xlink:href="https://covidiario.shinyapps.io/flowuti/" ext-link-type="uri">https://covidiario.shinyapps.io/flowuti/</ext-link>. The user’s database is held temporarily in the application and will be discarded when the session is terminated. Each data upload is only viewable by the user during that single browser session. We will ensure that the FlowUTI app is online for five years following the publication date, with a monthly usage limit of 25 hours. The source code of FlowUTI is available on GitHub (<ext-link xlink:href="https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI" ext-link-type="uri">https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI</ext-link>), which can be downloaded into any computer to be used offline without limitations by using the R software.</p>
    </sec>
    <sec id="sec007">
      <title>Datasets</title>
      <p>With the aim of evaluating FlowUTI, two datasets are analyzed in this manuscript. One of them (Neonate .csv) is composed of 204 urine samples from neonates and infants (≤ 3 months old) attended in the emergency department of the University Hospital Virgen del Rocío with suspected UTI during the years 2013–2015. All urine samples were obtained by bladder catheterization and held at 4°C until processed. All samples were processed within 2 hours after collection for culture and flow-cytometry analysis (UF-1000i, Sysmex). Counts above ≥10<sup>2</sup> colony-forming units (CFU)/ml were considered as positive cultures [<xref rid="pone.0277340.ref019" ref-type="bibr">19</xref>]. Regarding the second dataset (Elderly .csv), 1174 urine samples were included from an elderly population (≥65 years old) with UTI symptoms attended at the Primary Care Units of Virgen del Rocío University Hospital from January to December 2021. All samples were processed within 4–6 hours after collection for culture and flow-cytometry analysis (UF-5000, Sysmex). Counts above ≥10<sup>5</sup> CFU/ml were considered as positive cultures [<xref rid="pone.0277340.ref021" ref-type="bibr">21</xref>]. Both datasets are available on GitHub (<ext-link xlink:href="https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI/Demos" ext-link-type="uri">https://github.com/GuillermoMG-HUVR/Microbiology-applications/tree/FlowUTI/FlowUTI/Demos</ext-link>).</p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec008">
    <title>Results</title>
    <sec id="sec009">
      <title>Examples of use</title>
      <p>Below, we describe the use of FlowUTI for the screening of UTIs at the extreme-age groups: neonates and elderly. It is important to remark that the objective of this manuscript is not to determine a general cut-off value for these two groups of patients, but to highlight the importance of determining the cut-off values according to the patients analyzed. Therefore, the cut-offs evaluated by this study may not be useful in other centers.</p>
      <sec id="sec010">
        <title>Neonate dataset</title>
        <p>Once the Neonate .csv file is uploaded, we can observe a total of 204 records and two independent variables: bacteria and leukocytes. <xref rid="pone.0277340.t001" ref-type="table">Table 1</xref> summarizes the results obtained from the section <italic toggle="yes">Diagnostic accuracy</italic>. As can be observed, by selecting a cut-off value of 35 bacteria, a sensitivity of 100% is obtained, without false negative results, and with specificity and false positivity rates of 61% and 39%, respectively. Moreover, with this cut-off value we could avoid the culture of 44.11% of the urine samples. The higher the bacterial count selected as threshold, the higher the false negative rates. In the section <italic toggle="yes">Tables of sensitivity and specificity</italic>, an AUC of 0.948 was obtained, which means that bacterial count has an excellent discrimination capability for UTIs. On the other hand, leukocyte count appears not be as effective as the bacterial count as a screening of UTIs in this dataset, with an AUC of 0.808.</p>
        <table-wrap position="float" id="pone.0277340.t001">
          <object-id pub-id-type="doi">10.1371/journal.pone.0277340.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Bacteria and leukocyte count in urine specimens from neonates.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0277340.t001" id="pone.0277340.t001g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="2" colspan="1">Bacteria</th>
                  <th align="center" colspan="7" rowspan="1">% (CI)</th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">SE</th>
                  <th align="center" rowspan="1" colspan="1">SP</th>
                  <th align="center" rowspan="1" colspan="1">FP</th>
                  <th align="center" rowspan="1" colspan="1">FN</th>
                  <th align="center" rowspan="1" colspan="1">PPV</th>
                  <th align="center" rowspan="1" colspan="1">NPV</th>
                  <th align="center" rowspan="1" colspan="1">EF</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">35</td>
                  <td align="center" rowspan="1" colspan="1">100 (91–100)</td>
                  <td align="center" rowspan="1" colspan="1">61 (53–69)</td>
                  <td align="center" rowspan="1" colspan="1">39 (31–47)</td>
                  <td align="center" rowspan="1" colspan="1">0 (0–9)</td>
                  <td align="center" rowspan="1" colspan="1">50 (41–59)</td>
                  <td align="center" rowspan="1" colspan="1">100 (94–100)</td>
                  <td align="center" rowspan="1" colspan="1">72 (65–78)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">40</td>
                  <td align="center" rowspan="1" colspan="1">98 (91–100)</td>
                  <td align="center" rowspan="1" colspan="1">65 (56–72)</td>
                  <td align="center" rowspan="1" colspan="1">35 (28–44)</td>
                  <td align="center" rowspan="1" colspan="1">2 (0–9)</td>
                  <td align="center" rowspan="1" colspan="1">52(42–62)</td>
                  <td align="center" rowspan="1" colspan="1">99(94–100)</td>
                  <td align="center" rowspan="1" colspan="1">74 (67–80)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">45</td>
                  <td align="center" rowspan="1" colspan="1">98 (91–100)</td>
                  <td align="center" rowspan="1" colspan="1">67 (59–75)</td>
                  <td align="center" rowspan="1" colspan="1">33 (25–41)</td>
                  <td align="center" rowspan="1" colspan="1">2 (0–9)</td>
                  <td align="center" rowspan="1" colspan="1">54 (44–64)</td>
                  <td align="center" rowspan="1" colspan="1">99(95–100)</td>
                  <td align="center" rowspan="1" colspan="1">76(69–82)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">50</td>
                  <td align="center" rowspan="1" colspan="1">96 (88–100)</td>
                  <td align="center" rowspan="1" colspan="1">73 (65–80)</td>
                  <td align="center" rowspan="1" colspan="1">27 (20–35)</td>
                  <td align="center" rowspan="1" colspan="1">4 (0–12)</td>
                  <td align="center" rowspan="1" colspan="1">58 (47–68)</td>
                  <td align="center" rowspan="1" colspan="1">98 (94–100)</td>
                  <td align="center" rowspan="1" colspan="1">79 (73–85)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">60</td>
                  <td align="center" rowspan="1" colspan="1">95 (85–99)</td>
                  <td align="center" rowspan="1" colspan="1">75 (67–82)</td>
                  <td align="center" rowspan="1" colspan="1">25 (18–33)</td>
                  <td align="center" rowspan="1" colspan="1">5 (1–15)</td>
                  <td align="center" rowspan="1" colspan="1">59 (48–69)</td>
                  <td align="center" rowspan="1" colspan="1">97 (92–99)</td>
                  <td align="center" rowspan="1" colspan="1">80 (74–86)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">70</td>
                  <td align="center" rowspan="1" colspan="1">95 (85–99)</td>
                  <td align="center" rowspan="1" colspan="1">78 (70–84)</td>
                  <td align="center" rowspan="1" colspan="1">22 (16–30)</td>
                  <td align="center" rowspan="1" colspan="1">5 (1–15)</td>
                  <td align="center" rowspan="1" colspan="1">62 (51–72)</td>
                  <td align="center" rowspan="1" colspan="1">97 (93–99)</td>
                  <td align="center" rowspan="1" colspan="1">82 (76–87)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">100</td>
                  <td align="center" rowspan="1" colspan="1">88 (76–95)</td>
                  <td align="center" rowspan="1" colspan="1">85 (78–90)</td>
                  <td align="center" rowspan="1" colspan="1">15 (10–22)</td>
                  <td align="center" rowspan="1" colspan="1">12 (5–24)</td>
                  <td align="center" rowspan="1" colspan="1">69 (57–80)</td>
                  <td align="center" rowspan="1" colspan="1">95 (89–98)</td>
                  <td align="center" rowspan="1" colspan="1">86 (80–90)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
                    <bold>Leukocyte</bold>
                  </td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">1</td>
                  <td align="center" rowspan="1" colspan="1">100 (91–100)</td>
                  <td align="center" rowspan="1" colspan="1">3 (1–8)</td>
                  <td align="center" rowspan="1" colspan="1">97 (92–99)</td>
                  <td align="center" rowspan="1" colspan="1">0 (0–9)</td>
                  <td align="center" rowspan="1" colspan="1">29 (23–35)</td>
                  <td align="center" rowspan="1" colspan="1">100 (36–100)</td>
                  <td align="center" rowspan="1" colspan="1">30 (24–37)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">5</td>
                  <td align="center" rowspan="1" colspan="1">93 (83–98)</td>
                  <td align="center" rowspan="1" colspan="1">24 (17–32)</td>
                  <td align="center" rowspan="1" colspan="1">76 (69–83)</td>
                  <td align="center" rowspan="1" colspan="1">7 (2–17)</td>
                  <td align="center" rowspan="1" colspan="1">32 (25–40)</td>
                  <td align="center" rowspan="1" colspan="1">90 (76–97)</td>
                  <td align="center" rowspan="1" colspan="1">43 (36–50)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">10</td>
                  <td align="center" rowspan="1" colspan="1">90 (79–96)</td>
                  <td align="center" rowspan="1" colspan="1">46 (37–54)</td>
                  <td align="center" rowspan="1" colspan="1">54 (46–63)</td>
                  <td align="center" rowspan="1" colspan="1">10 (4–21)</td>
                  <td align="center" rowspan="1" colspan="1">39 (30–48)</td>
                  <td align="center" rowspan="1" colspan="1">92 (83–97)</td>
                  <td align="center" rowspan="1" colspan="1">58 (51–65)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">15</td>
                  <td align="center" rowspan="1" colspan="1">86 (74–94)</td>
                  <td align="center" rowspan="1" colspan="1">59 (51–67)</td>
                  <td align="center" rowspan="1" colspan="1">41 (33–49)</td>
                  <td align="center" rowspan="1" colspan="1">14 (6–26)</td>
                  <td align="center" rowspan="1" colspan="1">45 (35–55)</td>
                  <td align="center" rowspan="1" colspan="1">92 (84–96)</td>
                  <td align="center" rowspan="1" colspan="1">67 (60–73)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">20</td>
                  <td align="center" rowspan="1" colspan="1">81 (68–90)</td>
                  <td align="center" rowspan="1" colspan="1">67 (58–74)</td>
                  <td align="center" rowspan="1" colspan="1">33 (26–42)</td>
                  <td align="center" rowspan="1" colspan="1">19 (10–32)</td>
                  <td align="center" rowspan="1" colspan="1">48 (38–59)</td>
                  <td align="center" rowspan="1" colspan="1">90 (83–95)</td>
                  <td align="center" rowspan="1" colspan="1">71 (64–77)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">30</td>
                  <td align="center" rowspan="1" colspan="1">70 (57–82)</td>
                  <td align="center" rowspan="1" colspan="1">73 (66–80)</td>
                  <td align="center" rowspan="1" colspan="1">27 (20–34)</td>
                  <td align="center" rowspan="1" colspan="1">30 (18–43)</td>
                  <td align="center" rowspan="1" colspan="1">51 (39–62)</td>
                  <td align="center" rowspan="1" colspan="1">86 (79–92)</td>
                  <td align="center" rowspan="1" colspan="1">72 (66–79)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>SE: Sensitivity; SP: Specificity; FP: False positive; FN: False negative, PPV: Positive Predictive Value; NPV: Negative Predictive Value, EF: Effectiveness; CI: Confidence Interval 95%.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec011">
        <title>Elderly dataset</title>
        <p>In total, 1174 urine samples were included in the Elderly dataset (153 contaminated urines were discarded). We can observe that, with a bacteria cut-off value of 200 bacteria, a sensitivity of 95% is obtained, with a 5% of false negative results, a low value for sensitivity (56%) and a proportion of false positive of 44%. With these results, we could avoid the culture of 400 urine samples (34,07%). Again, the higher the bacterial count selected, the higher the false negative rates (<xref rid="pone.0277340.t002" ref-type="table">Table 2</xref>). The leukocyte count presents low specificity values. Finally, the AUCs for bacterial and leukocytes counts are 0.924 and 0.79, respectively.</p>
        <table-wrap position="float" id="pone.0277340.t002">
          <object-id pub-id-type="doi">10.1371/journal.pone.0277340.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Bacterial and leukocyte counts in urine specimens from elderly patients.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pone.0277340.t002" id="pone.0277340.t002g" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="2" colspan="1">Bacteria</th>
                  <th align="center" colspan="7" rowspan="1">% (CI)</th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">SE</th>
                  <th align="center" rowspan="1" colspan="1">SP</th>
                  <th align="center" rowspan="1" colspan="1">FP</th>
                  <th align="center" rowspan="1" colspan="1">FN</th>
                  <th align="center" rowspan="1" colspan="1">PPV</th>
                  <th align="center" rowspan="1" colspan="1">NPV</th>
                  <th align="center" rowspan="1" colspan="1">EF</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1">100</td>
                  <td align="center" rowspan="1" colspan="1">97 (95–98)</td>
                  <td align="center" rowspan="1" colspan="1">42 (38–46)</td>
                  <td align="center" rowspan="1" colspan="1">58 (54–62)</td>
                  <td align="center" rowspan="1" colspan="1">3 (2–5)</td>
                  <td align="center" rowspan="1" colspan="1">55 (52–58)</td>
                  <td align="center" rowspan="1" colspan="1">95 (92–97)</td>
                  <td align="center" rowspan="1" colspan="1">65 (62–68)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">150</td>
                  <td align="center" rowspan="1" colspan="1">96 (94–97)</td>
                  <td align="center" rowspan="1" colspan="1">50 (46–54)</td>
                  <td align="center" rowspan="1" colspan="1">50 (46–54)</td>
                  <td align="center" rowspan="1" colspan="1">4 (3–6)</td>
                  <td align="center" rowspan="1" colspan="1">58 (55–62)</td>
                  <td align="center" rowspan="1" colspan="1">94 (92–97)</td>
                  <td align="center" rowspan="1" colspan="1">69 (67–72)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">200</td>
                  <td align="center" rowspan="1" colspan="1">95 (93–97)</td>
                  <td align="center" rowspan="1" colspan="1">56 (52–59)</td>
                  <td align="center" rowspan="1" colspan="1">44 (41–48)</td>
                  <td align="center" rowspan="1" colspan="1">5 (3–7)</td>
                  <td align="center" rowspan="1" colspan="1">61 (58–65)</td>
                  <td align="center" rowspan="1" colspan="1">94 (92–96)</td>
                  <td align="center" rowspan="1" colspan="1">72 (70–75)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">300</td>
                  <td align="center" rowspan="1" colspan="1">94 (92–96)</td>
                  <td align="center" rowspan="1" colspan="1">64 (60–68)</td>
                  <td align="center" rowspan="1" colspan="1">36 (32–40)</td>
                  <td align="center" rowspan="1" colspan="1">6 (4–9)</td>
                  <td align="center" rowspan="1" colspan="1">66 (62–69)</td>
                  <td align="center" rowspan="1" colspan="1">94 (91–96)</td>
                  <td align="center" rowspan="1" colspan="1">77 (74–79)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">400</td>
                  <td align="center" rowspan="1" colspan="1">93 (90–95)</td>
                  <td align="center" rowspan="1" colspan="1">69 (65–72)</td>
                  <td align="center" rowspan="1" colspan="1">31 (28–35)</td>
                  <td align="center" rowspan="1" colspan="1">7 (5–10)</td>
                  <td align="center" rowspan="1" colspan="1">68 (65–72)</td>
                  <td align="center" rowspan="1" colspan="1">93 (90–95)</td>
                  <td align="center" rowspan="1" colspan="1">79 (76–81)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">
                    <bold>Leukocyte</bold>
                  </td>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">5</td>
                  <td align="center" rowspan="1" colspan="1">99 (97–100)</td>
                  <td align="center" rowspan="1" colspan="1">10 (8–13)</td>
                  <td align="center" rowspan="1" colspan="1">90 (87–92)</td>
                  <td align="center" rowspan="1" colspan="1">1 (0–3)</td>
                  <td align="center" rowspan="1" colspan="1">45 (42–48)</td>
                  <td align="center" rowspan="1" colspan="1">92 (83–97)</td>
                  <td align="center" rowspan="1" colspan="1">48 (45–51)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">10</td>
                  <td align="center" rowspan="1" colspan="1">97 (95–98)</td>
                  <td align="center" rowspan="1" colspan="1">16 (14–19)</td>
                  <td align="center" rowspan="1" colspan="1">84 (81–86)</td>
                  <td align="center" rowspan="1" colspan="1">3 (2–5)</td>
                  <td align="center" rowspan="1" colspan="1">46 (43–49)</td>
                  <td align="center" rowspan="1" colspan="1">87 (80–93)</td>
                  <td align="center" rowspan="1" colspan="1">50 (47–53)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">20</td>
                  <td align="center" rowspan="1" colspan="1">94 (91–95)</td>
                  <td align="center" rowspan="1" colspan="1">27 (24–31)</td>
                  <td align="center" rowspan="1" colspan="1">73 (69–76)</td>
                  <td align="center" rowspan="1" colspan="1">7 (4–9)</td>
                  <td align="center" rowspan="1" colspan="1">48 (45–52)</td>
                  <td align="center" rowspan="1" colspan="1">85 (80–90)</td>
                  <td align="center" rowspan="1" colspan="1">55 (53–58)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">30</td>
                  <td align="center" rowspan="1" colspan="1">91 (88–93)</td>
                  <td align="center" rowspan="1" colspan="1">36 (33–40)</td>
                  <td align="center" rowspan="1" colspan="1">64 (60–67)</td>
                  <td align="center" rowspan="1" colspan="1">9 (7–12)</td>
                  <td align="center" rowspan="1" colspan="1">51 (48–54)</td>
                  <td align="center" rowspan="1" colspan="1">84 (80–88)</td>
                  <td align="center" rowspan="1" colspan="1">59 (56–62)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">50</td>
                  <td align="center" rowspan="1" colspan="1">88 (85–91)</td>
                  <td align="center" rowspan="1" colspan="1">47 (43–51)</td>
                  <td align="center" rowspan="1" colspan="1">53 (49–56)</td>
                  <td align="center" rowspan="1" colspan="1">12 (9–15)</td>
                  <td align="center" rowspan="1" colspan="1">55 (51–58)</td>
                  <td align="center" rowspan="1" colspan="1">84 (80–88)</td>
                  <td align="center" rowspan="1" colspan="1">65 (62–67)</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">100</td>
                  <td align="center" rowspan="1" colspan="1">83 (79–86)</td>
                  <td align="center" rowspan="1" colspan="1">59 (55–62)</td>
                  <td align="center" rowspan="1" colspan="1">41 (38–45)</td>
                  <td align="center" rowspan="1" colspan="1">17 (14–21)</td>
                  <td align="center" rowspan="1" colspan="1">59 (56–63)</td>
                  <td align="center" rowspan="1" colspan="1">82 (79–85)</td>
                  <td align="center" rowspan="1" colspan="1">69 (66–71)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t002fn001">
              <p>SE: Sensitivity; SP: Specificity; FP: False positive; FN: False negative, PPV: Positive Predictive Value; NPV: Negative Predictive Value, EF: Effectiveness; CI: Confidence Interval 95%.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec012">
    <title>Discussion</title>
    <p>In this manuscript we present FlowUTI, a new interactive shiny web-application addressed to physicians and researchers interested in implementing and optimizing the use of flow-cytometry analyzers as a UTI screening method. FlowUTI is a free tool that provides a user-friendly graphical interface to perform robust statistical analysis without a specific training, maximizing the efficiency of the urinary screening process.</p>
    <p>The selection of appropriate cut-off values of a screening method is crucial to avoid erroneous diagnosis in clinical practice. Usually, the choice of cut-off values for bacteria or leukocytes are in accordance with the criterion formerly established by prior studies. However, there is a substantial heterogeneity of cut-off values applied among the studies, making it difficult to select one in particular. This issue was addressed in the meta-analysis performed by Shang and colleagues [<xref rid="pone.0277340.ref022" ref-type="bibr">22</xref>], where a dramatic heterogeneity (<italic toggle="yes">I</italic><sup>2</sup> &gt; 90%) on sensitivity, specificity, likelihood ratios and diagnostic odds ratios for both bacteria and leukocytes counts was observed. Another problem to be solved is the statistical methodology required to establish a general cut-off value by means of a meta-analysis, which is complex and cumbersome. Only recently a new R-package has been developed for this purpose [<xref rid="pone.0277340.ref023" ref-type="bibr">23</xref>], but an optimal threshold across all urine flow-cytometry studies has not been achieved yet.</p>
    <p>The selection of the best cut-off value depends on the prevalence of UTIs in the population, the diagnostic threshold selected, and the type of flow-cytometer used. Furthermore, the clinical relevance of the UTI is also a key factor. In this way, it’s only possible to determine the most appropriate cut-off value carefully considering the clinical cost of false-negative and false-positive results. UTIs in neonates and infants are associated with significant morbidity and long-term medical consequences [<xref rid="pone.0277340.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0277340.ref025" ref-type="bibr">25</xref>], and because antibiotic treatments have a profound impact on the gut microbiota [<xref rid="pone.0277340.ref026" ref-type="bibr">26</xref>], it’s crucial to promptly and accurately identify those patients who do not have the UTI. For this reason, high values of sensitivity and negative predictive values (NPV) are needed to limit false negative findings, even if the number of false-positive findings is high, resulting in additional cultures. Conversely, the utility of flow-cytometry in the elderly is challenging because of the high prevalence of bacteriuria and pyuria that may not be clinically relevant [<xref rid="pone.0277340.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0277340.ref028" ref-type="bibr">28</xref>]. For this reason, it’s important to perform a clinical evaluation about what is an acceptable number of false positive and false negative results. Moreover, the significant number of contaminated specimens in these patients [<xref rid="pone.0277340.ref029" ref-type="bibr">29</xref>] may cause erroneous interpretation of urine cultures, masking true infections, or leading to unnecessary treatments until diagnosis [<xref rid="pone.0277340.ref030" ref-type="bibr">30</xref>].</p>
    <p>FlowUTI is an open interactive application, which allows users to include different variables related with the UTI screening. For instance, the presence of squamous epithelial cells in urine during the sample collection procedure has been related with contaminated culture results [<xref rid="pone.0277340.ref031" ref-type="bibr">31</xref>]. Hence, users can include the epithelial cell counts and the “contaminated” result in the database, and then study the discrimination power of this variable and its utility to reduce the number of false positive results. Additionally, higher yeast-like cell counts by UF-5000 have been related with the presence of <italic toggle="yes">Candida</italic> spp. in urine samples [<xref rid="pone.0277340.ref032" ref-type="bibr">32</xref>], so it could be also interesting to evaluate this marker in selected patients [<xref rid="pone.0277340.ref033" ref-type="bibr">33</xref>].</p>
    <p>In conclusion, we expect that FlowUTI might be a useful tool for physicians and researchers, allowing them to interactively intervene on the choice of the best cut-off values, making it easier to analyze the data obtained from flow-cytometry and reducing the computational burden associated with this kind of analysis, without losing statistical reliability. We encourage clinical microbiology laboratories to establish their own cut-off values according to the patients attended. By doing so, they could decrease turnaround time of analysis and improving clinical decisions.</p>
  </sec>
</body>
<back>
  <ack>
    <p>Guillermo Martín-Gutiérrez holds a Juan Rodés Contract (JR19/00039) from the Carlos III Health Institute.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pone.0277340.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>RD</given-names></name>, <name><surname>Hultgren</surname><given-names>SJ</given-names></name>. <article-title>Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies</article-title>. <source>Nat Rev Microbiol</source>. <year>2020</year>; <volume>18</volume>:<fpage>211</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41579-020-0324-0</pub-id><?supplied-pmid 32071440?><pub-id pub-id-type="pmid">32071440</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Foxman</surname><given-names>B.</given-names></name><article-title>Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</article-title>. <source>Am J Med</source>. <year>2002</year>;<volume>113</volume><issue>Suppl 1A</issue>:<fpage>5S</fpage>–<lpage>13S</lpage>.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Church</surname><given-names>D</given-names></name>, <name><surname>Gregson</surname><given-names>D</given-names></name>. <article-title>Screening urine samples for significant bacteriuria in the clinical microbiology laboratory</article-title>, <source>Clin. Microbiol. Newsl</source>. <year>2004</year>; <volume>23</volume>:<fpage>179</fpage>–<lpage>83</lpage>.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Schifman</surname><given-names>RB</given-names></name>, <name><surname>Wieden</surname><given-names>M</given-names></name>, <name><surname>Brooker</surname><given-names>J</given-names></name>, <name><surname>Chery</surname><given-names>M</given-names></name>, <name><surname>Delduca</surname><given-names>M</given-names></name>, <name><surname>Norgard</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Bacteriuria screening by direct bioluminescence assay of ATP</article-title>. <source>J Clin Microbiol</source>. <year>1984</year>; <volume>20</volume>:<fpage>644</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/jcm.20.4.644-648.1984</pub-id><?supplied-pmid 6490851?><pub-id pub-id-type="pmid">6490851</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Okada</surname><given-names>H</given-names></name>, <name><surname>Sakai</surname><given-names>Y</given-names></name>, <name><surname>Miyazaki</surname><given-names>S</given-names></name>, <name><surname>Arakawa</surname><given-names>S</given-names></name>, <name><surname>Hamaguchi</surname><given-names>Y</given-names></name>, <name><surname>Kamidono</surname><given-names>S</given-names></name>. <article-title>Detection of significant bacteriuria by automated urinalysis using flow cytometry</article-title>. <source>J Clin Microbiol</source>. <year>2000</year>; <volume>38</volume>:<fpage>2870</fpage>–<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.38.8.2870-2872.2000</pub-id><?supplied-pmid 10921941?><pub-id pub-id-type="pmid">10921941</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Broeren</surname><given-names>MA</given-names></name>, <name><surname>Bahçeci</surname><given-names>S</given-names></name>, <name><surname>Vader</surname><given-names>HL</given-names></name>, <name><surname>Arents</surname><given-names>NL</given-names></name>. <article-title>Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer</article-title>. <source>J Clin Microbiol</source>. <year>2011</year>; <volume>49</volume>:<fpage>1025</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.01669-10</pub-id><?supplied-pmid 21248088?><pub-id pub-id-type="pmid">21248088</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Alvarez-Barrientos</surname><given-names>A</given-names></name>, <name><surname>Arroyo</surname><given-names>J</given-names></name>, <name><surname>Cantón</surname><given-names>R</given-names></name>, <name><surname>Nombela</surname><given-names>C</given-names></name>, <name><surname>Sánchez-Pérez</surname><given-names>M</given-names></name>. <article-title>Applications of flow cytometry to clinical microbiology</article-title>. <source>Clin Microbiol Rev</source>. <year>2000</year>; <volume>13</volume>:<fpage>167</fpage>–<lpage>95</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/CMR.13.2.167</pub-id><?supplied-pmid 10755996?><pub-id pub-id-type="pmid">10755996</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Manoni</surname><given-names>F</given-names></name>, <name><surname>Fornasiero</surname><given-names>L</given-names></name>, <name><surname>Ercolin</surname><given-names>M</given-names></name>, <name><surname>Tinello</surname><given-names>A</given-names></name>, <name><surname>Ferrian</surname><given-names>M</given-names></name>, <name><surname>Hoffer</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Cutoff values for bacteria and leukocytes for urine flow cytometer Sysmex UF-1000i in urinary tract infections</article-title>. <source>Diagn Microbiol Infect Dis</source>. <year>2009</year>; <volume>65</volume>:<fpage>103</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2009.06.003</pub-id><?supplied-pmid 19748419?><pub-id pub-id-type="pmid">19748419</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Jolkkonen</surname><given-names>S</given-names></name>, <name><surname>Paattiniemi</surname><given-names>EL</given-names></name>, <name><surname>Kärpänoja</surname><given-names>P</given-names></name>, <name><surname>Sarkkinen</surname><given-names>H</given-names></name>. <article-title>Screening of urine samples by flow cytometry reduces the need for culture</article-title>. <source>J Clin Microbiol</source>. <year>2010</year>; <volume>48</volume>:<fpage>3117</fpage>–<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.00617-10</pub-id><?supplied-pmid 20592157?><pub-id pub-id-type="pmid">20592157</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Mejuto</surname><given-names>P</given-names></name>, <name><surname>Luengo</surname><given-names>M</given-names></name>, <name><surname>Díaz-Gigante</surname><given-names>J</given-names></name>. <article-title>Automated Flow Cytometry: An Alternative to Urine Culture in a Routine Clinical Microbiology Laboratory?</article-title><source>Int J Microbiol</source>. <year>2017</year>; <volume>2017</volume>:<fpage>8532736</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2017/8532736</pub-id><?supplied-pmid 29090008?><pub-id pub-id-type="pmid">29090008</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Brenner</surname><given-names>H</given-names></name>, <name><surname>Gefeller</surname><given-names>O</given-names></name>. <article-title>Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence</article-title>. <source>Stat Med</source>. <year>1997</year>; <volume>16</volume>:<fpage>981</fpage>–<lpage>91</lpage>. <?supplied-pmid 9160493?><pub-id pub-id-type="pmid">9160493</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Hoberman</surname><given-names>A</given-names></name>, <name><surname>Chao</surname><given-names>HP</given-names></name>, <name><surname>Keller</surname><given-names>DM</given-names></name>, <name><surname>Hickey</surname><given-names>R</given-names></name>, <name><surname>Davis</surname><given-names>HW</given-names></name>, <name><surname>Ellis</surname><given-names>D</given-names></name>. <article-title>Prevalence of urinary tract infection in febrile infants</article-title>. <source>J Pediatr</source>. <year>1993</year>; <volume>123</volume>:<fpage>17</fpage>–<lpage>23</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0022-3476(05)81531-8</pub-id><?supplied-pmid 8320616?><pub-id pub-id-type="pmid">8320616</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Foxman</surname><given-names>B.</given-names></name><article-title>Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden</article-title>. <source>Infect Dis Clin North Am</source>. <year>2014</year>; <volume>28</volume>:<fpage>1</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.idc.2013.09.003</pub-id><?supplied-pmid 24484571?><pub-id pub-id-type="pmid">24484571</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref014">
      <label>14</label>
      <mixed-citation publication-type="other">European association of urology. Guidelines on urological infections. 2021. <ext-link xlink:href="https://uroweb.org/guidelines/urological-infections" ext-link-type="uri">https://uroweb.org/guidelines/urological-infections</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref015">
      <label>15</label>
      <mixed-citation publication-type="other">R Core Team. Vienna, Austria: R Foundation for statistical computing. 2021.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref016">
      <label>16</label>
      <mixed-citation publication-type="other">Chang W, Cheng J, Allaire JJ, Sievert C, Schloerke B, Xie Y et al. 2021. shiny: Web Application Framework for R. R package version 1.6.0, URL <ext-link xlink:href="https://CRAN.R-project.org/package=shiny" ext-link-type="uri">https://CRAN.R-project.org/package=shiny</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref017">
      <label>17</label>
      <mixed-citation publication-type="other">Stevenson M, Nunes T, Heuer C, Marshall C, Sanchez J, Thornton R, et al. epiR: Tools for the analysis of epidemiological data. CRAN repository. 2021.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Robin</surname><given-names>X</given-names></name>, <name><surname>Turck</surname><given-names>N</given-names></name>, <name><surname>Hainard</surname><given-names>A</given-names></name>, <name><surname>Tiberti</surname><given-names>N</given-names></name>, <name><surname>Lisacek</surname><given-names>F</given-names></name>, <name><surname>Sanchez</surname><given-names>JC</given-names></name><etal>et al</etal>. <article-title>pROC: an open-source package for R and S+ to analyze and compare ROC curves</article-title>. <source>BMC Bioinformatics</source>. <year>2011</year>; <volume>12</volume>:<fpage>77</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2105-12-77</pub-id><?supplied-pmid 21414208?><pub-id pub-id-type="pmid">21414208</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref019">
      <label>19</label>
      <mixed-citation publication-type="other">European association of urology. 2018. <ext-link xlink:href="https://uroweb.org/guidelines" ext-link-type="uri">https://uroweb.org/guidelines</ext-link>.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>de Cueto</surname><given-names>M</given-names></name>, <name><surname>Aliaga</surname><given-names>L</given-names></name>, <name><surname>Alós</surname><given-names>JI</given-names></name>, <name><surname>Canut</surname><given-names>A</given-names></name>, <name><surname>Los-Arcos</surname><given-names>I</given-names></name>, <name><surname>Martínez</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)</article-title>. <source>Enferm Infecc Microbiol Clin</source>. <year>2017</year>; <volume>35</volume>:<fpage>314</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.eimc.2016.11.005</pub-id><?supplied-pmid 28017477?><pub-id pub-id-type="pmid">28017477</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Nicolle</surname><given-names>L.</given-names></name><article-title>Symptomatic urinary tract infection or asymptomatic bacteriuria? Improving care for the elderly</article-title>. <source>Clin Microbiol Infect</source>. <year>2019</year>; <volume>25</volume>:<fpage>779</fpage>–<lpage>81</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cmi.2019.03.013</pub-id><?supplied-pmid 30922927?><pub-id pub-id-type="pmid">30922927</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Shang</surname><given-names>YJ</given-names></name>, <name><surname>Wang</surname><given-names>QQ</given-names></name>, <name><surname>Zhang</surname><given-names>JR</given-names></name>, <name><surname>Xu</surname><given-names>YL</given-names></name>, <name><surname>Zhang</surname><given-names>WW</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Systematic review and meta-analysis of flow cytometry in urinary tract infection screening</article-title>. <source>Clin Chim Acta</source>. <year>2013</year>; <volume>424</volume>:<fpage>90</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cca.2013.05.014</pub-id><?supplied-pmid 23721948?><pub-id pub-id-type="pmid">23721948</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Steinhauser</surname><given-names>S</given-names></name>, <name><surname>Schumacher</surname><given-names>M</given-names></name>, <name><surname>Rücker</surname><given-names>G</given-names></name>. <article-title>Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies</article-title>. <source>BMC Med Res Methodol</source>. <year>2016</year>; <volume>16</volume>:<fpage>97</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12874-016-0196-1</pub-id><?supplied-pmid 27520527?><pub-id pub-id-type="pmid">27520527</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Shortliffe</surname><given-names>LM</given-names></name>, <name><surname>McCue</surname><given-names>JD</given-names></name>. <article-title>Urinary tract infection at the age extremes: pediatrics and geriatrics</article-title>. <source>Am J Med</source>. <year>2002</year>;<volume>113</volume><issue>Suppl 1A</issue>:<fpage>55S</fpage>–<lpage>66S</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0002-9343(02)01060-4</pub-id><?supplied-pmid 12113872?><pub-id pub-id-type="pmid">12113872</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Saadeh</surname><given-names>SA</given-names></name>, <name><surname>Mattoo</surname><given-names>TK</given-names></name>. <article-title>Managing urinary tract infections</article-title>. <source>Pediatr Nephrol</source>. <year>2011</year>; <volume>26</volume>:<fpage>1967</fpage>–<lpage>76</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00467-011-1801-5</pub-id><?supplied-pmid 21409431?><pub-id pub-id-type="pmid">21409431</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Fjalstad</surname><given-names>JW</given-names></name>, <name><surname>Esaiassen</surname><given-names>E</given-names></name>, <name><surname>Juvet</surname><given-names>LK</given-names></name>, <name><surname>van den Anker</surname><given-names>JN</given-names></name>, <name><surname>Klingenberg</surname><given-names>C</given-names></name>. <article-title>Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review</article-title>. <source>J Antimicrob Chemother</source>. <year>2018</year>; <volume>73</volume>:<fpage>569</fpage>–<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jac/dkx426</pub-id><?supplied-pmid 29182785?><pub-id pub-id-type="pmid">29182785</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Mody</surname><given-names>L</given-names></name>, <name><surname>Juthani-Mehta</surname><given-names>M</given-names></name>. <article-title>Urinary tract infections in older women: a clinical review</article-title>. <source>JAMA</source>. <year>2014</year>; <volume>311</volume>:<fpage>844</fpage>–<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2014.303</pub-id><?supplied-pmid 24570248?><pub-id pub-id-type="pmid">24570248</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Schaeffer</surname><given-names>AJ</given-names></name>, <name><surname>Nicolle</surname><given-names>LE</given-names></name>. <article-title>CLINICAL PRACTICE. Urinary Tract Infections in Older Men</article-title>. <source>N Engl J Med</source>. <year>2016</year>; <volume>374</volume>:<fpage>562</fpage>–<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMcp1503950</pub-id><?supplied-pmid 26863357?><pub-id pub-id-type="pmid">26863357</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Hamilton-Miller</surname><given-names>JM</given-names></name>. <article-title>Issues in urinary tract infections in the elderly</article-title>. <source>World J Urol</source>. <year>1999</year>; <volume>17</volume>:<fpage>396</fpage>–<lpage>401</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s003450050165</pub-id><?supplied-pmid 10654370?><pub-id pub-id-type="pmid">10654370</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Kubik</surname><given-names>MJ</given-names></name>, <name><surname>McCarter</surname><given-names>YS</given-names></name>. <article-title>Controversies in the diagnosis of urinary tract infections</article-title>. <source>Clin Microbiol Newsl</source>. <year>2012</year>; <volume>34</volume>:<fpage>185</fpage>–<lpage>91</lpage>.</mixed-citation>
    </ref>
    <ref id="pone.0277340.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>García-Coca</surname><given-names>M</given-names></name>, <name><surname>Gadea</surname><given-names>I</given-names></name>, <name><surname>Esteban</surname><given-names>J</given-names></name>. <article-title>Relationship between conventional culture and flow cytometry for the diagnosis of urinary tract infection</article-title>. <source>J Microbiol Methods</source>. <year>2017</year>; <volume>137</volume>:<fpage>14</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mimet.2017.03.010</pub-id><?supplied-pmid 28330780?><pub-id pub-id-type="pmid">28330780</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SY</given-names></name>, <name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Koo</surname><given-names>SH</given-names></name>, <name><surname>Kwon</surname><given-names>GC</given-names></name>. <article-title>Rapid Screening of Urinary Tract Infection and Discrimination of Gram-Positive and Gram-Negative Bacteria by Automated Flow Cytometric Analysis Using Sysmex UF-5000</article-title>. <source>J Clin Microbiol</source>. <year>2018</year>;<volume>56</volume>:<fpage>e02004</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.02004-17</pub-id><?supplied-pmid 29769277?><pub-id pub-id-type="pmid">29769277</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0277340.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Gajdács</surname><given-names>M</given-names></name>, <name><surname>Dóczi</surname><given-names>I</given-names></name>, <name><surname>Ábrók</surname><given-names>M</given-names></name>, <name><surname>Lázár</surname><given-names>A</given-names></name>, <name><surname>Burián</surname><given-names>K</given-names></name>. <article-title>Epidemiology of candiduria and <italic toggle="yes">Candida</italic> urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey</article-title>. <source>Cent European J Urol</source>. <year>2019</year>;<volume>72</volume>:<fpage>209</fpage>–<lpage>14</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
